Aj. Strong et al., Factors influencing the frequency of fluorescence transients as markers ofperi-infarct depolarizations in focal cerebral ischemia, STROKE, 31(1), 2000, pp. 214-221
Background and Purpose-Peri-infarct depolarizations (PIDs) that occur in is
chemic boundary zones of the cerebral cortex of experimental animals have b
een shown to promote rather than simply to indicate the evolution of the le
sion and are especially prominent in the rat. To study the influence of one
factor, species, on PID incidence, we compared the frequency of PIDs in a
primate species, the squirrel monkey, with that in the cat after middle cer
ebral artery occlusion. Plasma glucose was reviewed as a possible cause of
interexperiment variability in the cat experiments.
Methods-In open-skull experiments under chloralose anesthesia, changes in c
ortical fluorescence believed to indicate NADH/NAD(+) redox state, as marke
rs of PIDs, were recorded by serial imaging of the cortical surface in vivo
for 4 hours after middle cerebral artery occlusion.
Results-Fluorescence transients occurred in squirrel monkeys at a frequency
(mean+/-SD) of 0.7+/-0.8 hours(-1) (n=5), which was not significantly less
than in that observed in cats (1.3+/-1.6 hours(-1), n=S). Data from the ca
t experiments indicated a relationship between number of transients (depend
ent) and plasma glucose, with a striking increase in PLD frequency in assoc
iation with values of mean postocclusion plasma glucose <4.1 mmol/L (Mann-W
hitney U=15.0, P=0.034); this observation agrees well with other published
findings.
Conclusions-Transient changes in fluorescence strongly suggestive of peri-i
nfarct depolarizations, either transient or terminal, occur and propagate i
n the ischemic cerebral cortex of a nonhuman primate. The results also sugg
est that the relationship of frequency of peri-infarct depolarizations with
plasma glucose requires further examination, to confirm the finding and to
determine a safe lower limit for a target range for control of plasma gluc
ose if insulin is used in the management of patients with cerebral ischemia
.